Literature DB >> 10362643

CCK receptor dysfunction in muscle membranes from human gallbladders with cholesterol stones.

Z L Xiao1, Q Chen, J Amaral, P Biancani, R T Jensen, J Behar.   

Abstract

Human gallbladders with cholesterol stones exhibit impaired muscle contraction induced by agonists that act on transmembrane receptors, increased membrane cholesterol content, and abnormal cholesterol-to-phospholipid ratio compared with those with pigment stones. The present study was designed to investigate the functions of the CCK receptor of gallbladder muscle membranes by radioreceptor assay and cross-linking. 125I-labeled CCK-8 binding was time-dependent, competitive, and specific. Scatchard analysis showed that the maximum specific binding (Bmax) was significantly decreased in cholesterol compared with pigment stone gallbladders (0.18 +/- 0. 07 vs. 0.38 +/- 0.05 pmol/mg protein, P < 0.05). In contrast, the affinity for CCK was higher in cholesterol than pigment stone gallbladders (0.18 +/- 0.06 vs. 1.2 +/- 0.23 nM). Similar results were observed in binding studies with the CCK-A receptor antagonist [3H]L-364,718. Cross-linking and saturation binding studies also showed significantly less CCK binding in gallbladders with cholesterol stones. These abnormalities were reversible after incubation with cholesterol-free liposomes. The Bmax increased (P < 0.01) and the dissociation constant decreased (P < 0.001) after incubation with cholesterol-free liposomes. In conclusion, human gallbladders with cholesterol stones have impaired CCK receptor binding compared with those with pigment stones. These changes are reversed by removal of the excess membrane cholesterol. These receptor alterations may contribute to the defective contractility of the gallbladder muscle in patients with cholesterol stones.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10362643     DOI: 10.1152/ajpgi.1999.276.6.G1401

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  41 in total

1.  Pharmacological evidence for putative CCK(1) receptor heterogeneity in human colon smooth muscle.

Authors:  M F Morton; E A Harper; I A Tavares; N P Shankley
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

2.  Differential sensitivity of types 1 and 2 cholecystokinin receptors to membrane cholesterol.

Authors:  Ross M Potter; Kaleeckal G Harikumar; S Vincent Wu; Laurence J Miller
Journal:  J Lipid Res       Date:  2011-10-21       Impact factor: 5.922

3.  The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.

Authors:  Helen H Wang; Piero Portincasa; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2016-01-12       Impact factor: 4.686

Review 4.  The serotonin1A receptor: a representative member of the serotonin receptor family.

Authors:  Thomas J Pucadyil; Shanti Kalipatnapu; Amitabha Chattopadhyay
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

5.  Estrogen induces two distinct cholesterol crystallization pathways by activating ERα and GPR30 in female mice.

Authors:  Ornella de Bari; Tony Y Wang; Min Liu; Piero Portincasa; David Q-H Wang
Journal:  J Lipid Res       Date:  2015-07-07       Impact factor: 5.922

6.  Temperature dependence of the sodium pump is altered in the cerebral cortex of CCK2 receptor-deficient mice.

Authors:  T Salum; S Kõks; C Kairane; R Mahlapuu; M Zilmer; E Vasar
Journal:  Neurochem Res       Date:  2010-01-08       Impact factor: 3.996

Review 7.  Changes in the plasma membrane in metabolic disease: impact of the membrane environment on G protein-coupled receptor structure and function.

Authors:  Aditya J Desai; Laurence J Miller
Journal:  Br J Pharmacol       Date:  2017-08-03       Impact factor: 8.739

8.  Cholelithiatic human gallbladders in vitro fail to respond to cholecystokinin but are responsive to carbachol, histamine, or electrical stimulation.

Authors:  Shripad B Deshpande; Narendra K Gupta; Vijay K Shukla
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

9.  Association of cholecystokinin A receptor gene polymorphism with cholelithiasis and the molecular mechanisms of this polymorphism.

Authors:  Kyoko Miyasaka; Yutaka Takata; Akihiro Funakoshi
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

10.  Targeted disruption of the murine cholecystokinin-1 receptor promotes intestinal cholesterol absorption and susceptibility to cholesterol cholelithiasis.

Authors:  David Q-H Wang; Frank Schmitz; Alan S Kopin; Martin C Carey
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.